UK markets close in 4 hours 15 minutes

Iovance Biotherapeutics, Inc. (0JDK.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
12.16-0.09 (-0.73%)
As of 07:13PM BST. Market open.

Insider roster

Individual or entityMost-recent transactionDateShares owned as of transaction date

BELLEMIN JEAN-MARC
Chief Financial Officer

Conversion of Exercise of derivative security

03 Jan 2023

17,801

BILINSKY IGOR P
Chief Operating Officer

Conversion of Exercise of derivative security

15 Apr 2024

38,026

DUKES IAIN D
Director

Purchase

20 Feb 2024

54,000

GRAF FINCKENSTEIN FRIEDRICH
Officer

Conversion of Exercise of derivative security

15 Apr 2024

42,562

MAYNARD RYAN D
Director

Purchase

31 May 2022

7,500

MCPEAK MERRILL A
Director

Purchase

20 Feb 2024

568,783

VOGT FREDERICK G
Chief Executive Officer

Conversion of Exercise of derivative security

15 Apr 2024

141,334

WEISER MICHAEL
Director

Purchase

31 May 2022

141,116

*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.